Monoperber

monoperber is recommended only if there are no other options. This difference could be entirely due to confounding by gender, because about eight % more women ended up in the multiparave group. All patients in all four studies were un vaccinated so it is totally unknown at this point what the effect of these medications will be on risk reduction for high risk vaccinated patients.